0000000000787322

AUTHOR

Andrew Menzies Gow

showing 1 related works from this author

Care pathways for the selection of a biologic in severe asthma.

2017

Physicians need care pathways to select a biologic in type 2 severe asthma (omalizumab, mepolizumab, reslizumab) http://ow.ly/pygw30gB7Bv

Pulmonary and Respiratory Medicinemedicine.medical_specialtySevere asthmaMEDLINEmacromolecular substancesOmalizumab03 medical and health sciences0302 clinical medicineReslizumabmedicineHumans030212 general & internal medicineIntensive care medicineSelection (genetic algorithm)Randomized Controlled Trials as TopicAsthma therapyBiological Productsbusiness.industryAntibodies MonoclonalAsthma030228 respiratory systemPractice Guidelines as TopicCritical PathwaysbusinessMepolizumabmedicine.drugThe European respiratory journal
researchProduct